2032 年腸道健康和微生物組補充劑市場預測：按產品類型、成分、配方、分銷管道、應用、最終用戶和地區進行的全球分析

根據 Stratistics MRC 的數據，全球腸道健康和微生物組補充劑市場預計在 2025 年達到 144 億美元，到 2032 年將達到 261 億美元，預測期內的複合年成長率為 8.8%。

腸道健康和微生物組市場專注於益生菌、益生元、合益素、後生元以及旨在透過腸道微生物組支持消化健康、免疫功能和整體健康的定製配方。越來越多的科學證據顯示微生物組平衡與健康結果息息相關，對預防性醫療保健的興趣日益濃厚，以及消費者對個人化營養的需求推動了市場的成長。菌株特異性研究、遞送系統和臨床檢驗的進展也增強了可信度。

根據國際食品資訊委員會（IFIC）2022年的一項調查，四分之一的美國認為腸道健康是他們整體健康中最重要的方面，這表明消費者對相關產品的認知度和需求很高。

對天然和植物性補充劑的需求不斷成長

這一市場很大程度上是由消費者對天然和植物來源健康解決方案的強烈偏好所驅動。現今的消費者對合成成分越來越謹慎，並尋求標籤更乾淨、來源更明確的產品。越來越多的研究檢驗了植物成分以及天然來源的益生菌和益生元的有效性，進一步強化了這個趨勢。因此，製造商正在大力投資開發非基因改造、有機和永續的植物來源補充劑，這些補充劑直接符合注重健康的消費者的道德規範，並透過有針對性的產品創新和行銷來推動市場擴張。

高級補充品配方高成本

阻礙更廣泛市場滲透的一個主要因素是高級微生物組補充劑的高價格。這些產品通常包含經過臨床研究的取得專利的菌株、先進的給藥系統（例如延遲釋放膠囊）以及嚴格的第三方效力和純度測試。相關的研發和品質保證成本高昂，並轉嫁給消費者。這給了很大一部分潛在買家（尤其是在價格敏感的新興市場）造成了巨大的價格壁壘，從而抑制了整體市場的成長。

將補充劑與機能性食品和飲料結合

益生菌果汁、益生元能量棒和發酵飲料等強化產品提供了便利、個人化的攝取選擇，吸引了那些不喜歡吞服藥丸的人。這項策略有效地將市場從傳統的補充劑使用者拓展到更廣泛的注重健康的消費者群體。此外，鼓勵每日堅持並持續支持微生物組，為補充劑製造商與食品飲料公司之間的跨行業合作提供了重要機會。

潛在的副作用和不良反應

該市場面臨潛在副作用的持續威脅，包括初期腹脹、脹氣以及免疫力缺乏人群中更嚴重的副作用。一旦發生這些副作用，可能會導致消費者負面評價和產品退貨，嚴重的情況甚至會面臨法律挑戰和監管審查。此類事件會迅速削弱消費者對品牌或更廣泛的補充劑類別的信任。保持標籤透明、劑量和使用說明清晰，並投入資金進行消費者教育，對於減輕這些威脅並維護市場信譽至關重要。

COVID-19的影響：

疫情催生了腸道健康補充品市場。廣泛的研究表明，健康的腸道菌群與強大的免疫功能息息相關，這導致益生菌和益生元的需求激增。然而，由於全球供應鏈和原料採購中斷導致暫時供不應求和生產延遲，這一成長最初有所放緩。疫情的持續影響提高了消費者對主動健康管理的意識，市場最終也做出了調整。

益生菌市場預計將成為預測期內最大的市場

益生菌類別預計將佔據最大的市場佔有率，這得益於其紮實的科學檢驗和消費者的深度熟悉。數十年的臨床研究已確鑿證明，特定的益生菌菌株有益於消化器官系統健康、免疫支持，甚至心理健康，這使得消費者和醫療保健專業人士對這些產品擁有高度的信任。此外，益生菌是微生物組領域最成熟、定義最明確的類別，擁有廣泛的市售選擇。這種穩固的市場地位和經過驗證的有效性，使益生菌成為大多數尋求腸道健康解決方案的消費者的預設和最值得信賴的選擇。

預計在預測期內，液體和軟糖部分將以最高的複合年成長率成長。

預計液體和軟糖細分市場將實現最高成長率，這得益於消費者偏好從根本上轉向美味便捷的補充劑形式。這些給藥方式對關鍵族群尤其具有吸引力，包括兒童、老年人以及吞嚥傳統片劑和膠囊有困難的人。此外，軟糖的宜人口感和易咀嚼的特性提高了每日補充劑攝取的依從性。市場細分正利用這一趨勢，推出無糖、天然香料和高活性配方等創新產品，使該市場成為最具活力、成長最快的細分市場之一。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。這一主導地位可歸因於幾個關鍵因素，包括消費者健康意識的增強、高可支配收入以及完善的膳食補充劑零售和電商基礎。該地區擁有成熟的消費者群體，他們對腸道健康與免疫系統之間的聯繫瞭如指掌，推動了持續的需求。此外，主要市場參與者的存在、積極的行銷策略以及能夠增強消費者信心的強大法律規範，鞏固了北美在市場上的主導地位。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這一爆炸性成長的驅動力在於快速壯大的中等收入階層，他們可支配收入不斷增加，健康意識不斷增強，預防性保健意識也日益增強。都市化和西方健康趨勢的影響使消費者更容易接受膳食補充劑。此外，中國和印度等國家擁有龐大的人口基數，蘊藏著巨大的尚未開發的市場機會。本土製造商也積極開發符合當地需求且價格實惠的產品，形成了一個充滿活力且快速成長的市場格局。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

• 公司簡介
  • 全面分析其他市場參與者（最多 3 家公司）
  • 主要企業的SWOT分析（最多3家公司）
• 區域細分
  • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業進行基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 調查範圍
• 調查方法
  • 資料探勘
  • 數據分析
  • 數據檢驗
  • 研究途徑
• 研究材料
  • 主要研究資料
  • 二手研究資料
  • 先決條件

第3章市場走勢分析

• 驅動程式
• 抑制因素
• 機會
• 威脅
• 產品分析
• 應用分析
• 最終用戶分析
• 新興市場
• COVID-19的影響

第4章 波特五力分析

• 供應商的議價能力
• 買方的議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭對手之間的競爭

5. 全球腸道健康和微生物組補充劑市場（按產品類型）

• 益生菌
• 益生元
• 合益素
• 後生元
• 酵素
• 其他產品類型

6. 全球腸道健康和微生物組補充劑市場（按成分）

• 細菌
• 酵母菌
• 纖維

7. 全球腸道健康和微生物組補充劑市場（按配方）

• 膠囊和片劑
• 粉末小袋
• 液體和軟糖

8. 全球腸道健康和微生物組補充劑市場（按分銷管道）

• 大賣場/超級市場
• 藥局和藥局
• 網上零售/電子商務
• 專賣店

9. 全球腸道健康和微生物組補充劑市場（按應用）

• 消化器官系統健康
• 免疫支持
• 體重管理
• 心理和認知健康
• 其他用途

10. 全球腸道健康和微生物組補充劑市場（按最終用戶）

• 成人
• 孩子
• 老年人

11. 全球腸道健康和微生物組補充劑市場（按地區）

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東和非洲地區

第12章 重大進展

• 協議、夥伴關係、合作和合資企業
• 收購與合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第13章：企業概況

• Nestle Health Science
• Bayer AG
• Church & Dwight Co., Inc.
• NOW Health Group
• Danone SA
• Procter & Gamble Co.
• BioGaia AB
• Dr. Willmar Schwabe GmbH & Co. KG
• Amway Corporation
• Reckitt Benckiser Group plc
• DSM-Firmenich
• Yakult Honsha Co., Ltd.
• Seed Health, Inc.
• Pendulum Therapeutics
• BIOHM Health
• Seres Therapeutics, Inc.
• Ferring BV
• BiomeBank
• International Flavors & Fragrances Inc.（IFF）
• OptiBiotix Health Plc

According to Stratistics MRC, the Global Gut Health and Microbiome Supplement Market is accounted for $14.4 billion in 2025 and is expected to reach $26.1 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Gut health and microbiome market focuses on probiotics, prebiotics, synbiotics, postbiotics, and tailored formulations aimed at supporting digestive health, immune function, and overall wellbeing via the gut microbiome. Growth is driven by expanding scientific evidence linking microbiome balance to health outcomes, rising preventive healthcare interest, and consumer demand for personalized nutrition. Advances in strain-specific research, delivery systems, and clinical validation enhance credibility.

According to a 2022 survey by the International Food Information Council (IFIC), one in four Americans considered gut health to be the most important aspect of their overall health, indicating high consumer awareness and demand for related products.

Market Dynamics:

Driver:

Growing demand for natural and plant-based supplements

The market is significantly propelled by a pronounced consumer pivot towards natural and plant-based wellness solutions. Modern consumers are increasingly wary of synthetic ingredients, seeking cleaner labels and products derived from recognizable sources. This trend is amplified by a growing body of research validating the efficacy of botanicals and natural strains of probiotics and prebiotics. Consequently, manufacturers are heavily investing in developing supplements from non-GMO, organic, and sustainable plant sources, directly aligning with this health-conscious consumer ethos and driving market expansion through targeted product innovation and marketing.

Restraint:

High cost of advanced supplement formulations

A primary factor limiting broader market penetration is the elevated price point of advanced microbiome supplements. These products often incorporate clinically studied, patented bacterial strains, sophisticated delivery systems like delayed-release capsules, and rigorous third-party testing for potency and purity. The associated research, development, and quality assurance costs are substantial and are passed on to the consumer. This creates a significant price barrier for a large segment of potential buyers, particularly in price-sensitive emerging markets, thereby restricting the overall market growth.

Opportunity:

Integration of supplements with functional foods and beverages

The fortification of products like probiotic juices, prebiotic snack bars, and fermented drinks offers a convenient and discrete consumption method, appealing to those who dislike swallowing pills. This strategy effectively expands the market reach beyond traditional supplement users to a broader health-aware demographic. Moreover, it encourages daily adherence and allows for continuous microbiome support, presenting a significant opportunity for cross-industry collaboration between supplement manufacturers and food and beverage companies.

Threat:

Potential side effects and adverse reactions

The market faces a persistent threat from the potential for side effects, such as initial bloating, gas, or more serious adverse reactions in immunocompromised individuals. These incidents, when they occur, can lead to negative consumer reviews, product returns, and in severe cases, legal challenges or regulatory scrutiny. Such events can rapidly erode consumer trust in a brand or even the broader supplement category. Maintaining transparent labeling, clear dosage instructions, and investing in consumer education is crucial to mitigate this threat and uphold the market's credibility.

Covid-19 Impact:

The pandemic served as a catalyst for the gut health supplement market, as consumers became intensely focused on bolstering their innate immunity. Widespread research linking a healthy gut microbiome to robust immune function drove a surge in demand for probiotics and prebiotics. However, this growth was tempered by initial disruptions in the global supply chain and raw material sourcing, leading to temporary shortages and production delays. The market ultimately adapted, with the pandemic leaving a lasting legacy of heightened consumer awareness about proactive health management.

The probiotics segment is expected to be the largest during the forecast period

The probiotics segment is projected to account for the largest market share, a dominance rooted in strong scientific validation and deep-rooted consumer familiarity. Decades of clinical research have conclusively established the benefits of specific probiotic strains for digestive wellness, immune support, and even mental health, giving consumers and healthcare professionals high confidence in these products. Furthermore, probiotics represent the most mature and well-defined category within the microbiome space, with an extensive range of over-the-counter options available. This established market presence and proven efficacy make probiotics the default and most trusted choice for a majority of consumers seeking gut health solutions.

The liquids & gummies segment is expected to have the highest CAGR during the forecast period

The liquids and gummies segment is anticipated to register the highest growth rate, driven by a fundamental shift in consumer preference towards enjoyable and convenient supplement formats. These delivery systems are particularly appealing to key demographics such as children, seniors, and anyone who has difficulty swallowing traditional pills or capsules. Additionally, the pleasant taste and chewable nature of gummies improve adherence to daily supplement regimens. Manufacturers are capitalizing on this trend by innovating with sugar-free options, natural flavors, and high-potency formulations, making this the most dynamic and rapidly expanding segment in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This leadership position is attributed to several key factors, including high consumer health awareness, strong disposable income, and a well-established retail and e-commerce infrastructure for dietary supplements. The region has a mature consumer base that is well-informed about the gut-health-immune-system connection, driving consistent demand. Moreover, the presence of major market players, aggressive marketing strategies, and a robust regulatory framework that inspires consumer confidence collectively solidify North America's dominant position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This explosive growth is fueled by a rapidly expanding middle class with increasing disposable income, rising health consciousness, and growing awareness of preventive healthcare. Urbanization and the influence of Western health trends are making consumers more receptive to dietary supplements. Furthermore, the vast population base in countries like China and India presents an immense, yet under-penetrated, market opportunity. Local manufacturers are also actively developing affordable products tailored to regional preferences, creating a highly dynamic and fast-growing market landscape.

Key players in the market

Some of the key players in Gut Health and Microbiome Supplement Market include Nestle Health Science, Bayer AG, Church & Dwight Co., Inc., NOW Health Group, Danone S.A., Procter & Gamble Co., BioGaia AB, Dr. Willmar Schwabe GmbH & Co. KG, Amway Corporation, Reckitt Benckiser Group plc, DSM-Firmenich, Yakult Honsha Co., Ltd., Seed Health, Inc., Pendulum Therapeutics, BIOHM Health, Seres Therapeutics, Inc., Ferring B.V., BiomeBank, International Flavors & Fragrances Inc. (IFF), and OptiBiotix Health Plc.

Key Developments:

In June 2025, Danone announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. Expanding deeper into gut health is a key facet of Danone's Renew strategy, as it doubles down on science and innovation, and as consumer interest in healthy products continues to rise.

In April 2025, DSM-Firmenich launched its Healthy Longevity innovation platform at Vitafoods Europe 2025, focusing on gut health and healthy aging.

In March 2024, Garden of Life, a Nestle Health Science brand, launched Non-GMO and USDA Organic Certified probiotics within its sports nutrition portfolio promoting digestive health.

Product Types Covered:

• Probiotics
• Prebiotics
• Synbiotics
• Postbiotics
• Enzymes
• Other Product Types

Ingredients Covered:

• Bacteria
• Yeast
• Fibers

Formulations Covered:

• Capsules & Tablets
• Powder & Sachets
• Liquids & Gummies

Distribution Channels Covered:

• Hypermarkets/Supermarkets
• Pharmacies & Drug Stores
• Online Retail/E-commerce
• Specialty Stores

Applications Covered:

• Digestive Health
• Immune Support
• Weight Management
• Mental & Cognitive Health
• Other Applications

End Users Covered:

• Adults
• Children
• Elderly

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Gut Health and Microbiome Supplement Market, By Product Type

• 5.1 Introduction
• 5.2 Probiotics
• 5.3 Prebiotics
• 5.4 Synbiotics
• 5.5 Postbiotics
• 5.6 Enzymes
• 5.7 Other Product Types

6 Global Gut Health and Microbiome Supplement Market, By Ingredient

• 6.1 Introduction
• 6.2 Bacteria
• 6.3 Yeast
• 6.4 Fibers

7 Global Gut Health and Microbiome Supplement Market, By Formulation

• 7.1 Introduction
• 7.2 Capsules & Tablets
• 7.3 Powder & Sachets
• 7.4 Liquids & Gummies

8 Global Gut Health and Microbiome Supplement Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Hypermarkets/Supermarkets
• 8.3 Pharmacies & Drug Stores
• 8.4 Online Retail/E-commerce
• 8.5 Specialty Stores

9 Global Gut Health and Microbiome Supplement Market, By Application

• 9.1 Introduction
• 9.2 Digestive Health
• 9.3 Immune Support
• 9.4 Weight Management
• 9.5 Mental & Cognitive Health
• 9.6 Other Applications

10 Global Gut Health and Microbiome Supplement Market, By End User

• 10.1 Introduction
• 10.2 Adults
• 10.3 Children
• 10.4 Elderly

11 Global Gut Health and Microbiome Supplement Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Nestle Health Science
• 13.2 Bayer AG
• 13.3 Church & Dwight Co., Inc.
• 13.4 NOW Health Group
• 13.5 Danone S.A.
• 13.6 Procter & Gamble Co.
• 13.7 BioGaia AB
• 13.8 Dr. Willmar Schwabe GmbH & Co. KG
• 13.9 Amway Corporation
• 13.10 Reckitt Benckiser Group plc
• 13.11 DSM-Firmenich
• 13.12 Yakult Honsha Co., Ltd.
• 13.13 Seed Health, Inc.
• 13.14 Pendulum Therapeutics
• 13.15 BIOHM Health
• 13.16 Seres Therapeutics, Inc.
• 13.17 Ferring B.V.
• 13.18 BiomeBank
• 13.19 International Flavors & Fragrances Inc. (IFF)
• 13.20 OptiBiotix Health Plc

List of Tables

• Table 1 Global Gut Health and Microbiome Supplement Market Outlook, By Region (2024-2032) ($MN)
• Table 2 Global Gut Health and Microbiome Supplement Market Outlook, By Product Type (2024-2032) ($MN)
• Table 3 Global Gut Health and Microbiome Supplement Market Outlook, By Probiotics (2024-2032) ($MN)
• Table 4 Global Gut Health and Microbiome Supplement Market Outlook, By Prebiotics (2024-2032) ($MN)
• Table 5 Global Gut Health and Microbiome Supplement Market Outlook, By Synbiotics (2024-2032) ($MN)
• Table 6 Global Gut Health and Microbiome Supplement Market Outlook, By Postbiotics (2024-2032) ($MN)
• Table 7 Global Gut Health and Microbiome Supplement Market Outlook, By Enzymes (2024-2032) ($MN)
• Table 8 Global Gut Health and Microbiome Supplement Market Outlook, By Other Product Types (2024-2032) ($MN)
• Table 9 Global Gut Health and Microbiome Supplement Market Outlook, By Ingredient (2024-2032) ($MN)
• Table 10 Global Gut Health and Microbiome Supplement Market Outlook, By Bacteria (2024-2032) ($MN)
• Table 11 Global Gut Health and Microbiome Supplement Market Outlook, By Yeast (2024-2032) ($MN)
• Table 12 Global Gut Health and Microbiome Supplement Market Outlook, By Fibers (2024-2032) ($MN)
• Table 13 Global Gut Health and Microbiome Supplement Market Outlook, By Formulation (2024-2032) ($MN)
• Table 14 Global Gut Health and Microbiome Supplement Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
• Table 15 Global Gut Health and Microbiome Supplement Market Outlook, By Powder & Sachets (2024-2032) ($MN)
• Table 16 Global Gut Health and Microbiome Supplement Market Outlook, By Liquids & Gummies (2024-2032) ($MN)
• Table 17 Global Gut Health and Microbiome Supplement Market Outlook, By Distribution Channel (2024-2032) ($MN)
• Table 18 Global Gut Health and Microbiome Supplement Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
• Table 19 Global Gut Health and Microbiome Supplement Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
• Table 20 Global Gut Health and Microbiome Supplement Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
• Table 21 Global Gut Health and Microbiome Supplement Market Outlook, By Specialty Stores (2024-2032) ($MN)
• Table 22 Global Gut Health and Microbiome Supplement Market Outlook, By Application (2024-2032) ($MN)
• Table 23 Global Gut Health and Microbiome Supplement Market Outlook, By Digestive Health (2024-2032) ($MN)
• Table 24 Global Gut Health and Microbiome Supplement Market Outlook, By Immune Support (2024-2032) ($MN)
• Table 25 Global Gut Health and Microbiome Supplement Market Outlook, By Weight Management (2024-2032) ($MN)
• Table 26 Global Gut Health and Microbiome Supplement Market Outlook, By Mental & Cognitive Health (2024-2032) ($MN)
• Table 27 Global Gut Health and Microbiome Supplement Market Outlook, By Other Applications (2024-2032) ($MN)
• Table 28 Global Gut Health and Microbiome Supplement Market Outlook, By End User (2024-2032) ($MN)
• Table 29 Global Gut Health and Microbiome Supplement Market Outlook, By Adults (2024-2032) ($MN)
• Table 30 Global Gut Health and Microbiome Supplement Market Outlook, By Children (2024-2032) ($MN)
• Table 31 Global Gut Health and Microbiome Supplement Market Outlook, By Elderly (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.